Table 3 Univariate analysis for local control and overall survival
| Â | Local control | Overall survival | ||
|---|---|---|---|---|
Variable | HR (95% CI) | p | HR (95% CI) | p |
Location§ | 0.554 (0.111-2.772) | 0.472 | 0.847 (0.4364-1.970) | 0.700 |
GTV diameter (cm) | 0.809 (0.613-1.068) | 0.135 | 1.005 (0.900-1.122) | 0.933 |
CA 19-9 (U/ml) | 1.000 (1.000-1.001) | 0.506 | 1.000 (1.000-1.000) | 0.113 |
Bilirubin (mg/dl) | 1.003 (0.838-1.201) | 0.972 | 0.970 (0.861-1.093) | 0.618 |
PTV Volume (cm3) | 0.997 (0.992-1.001) | 0.163 | 1.000 (0.999-1.002) | 0.892 |
Prescribed dose (Gy) | 0.749 (0.461-1.217) | 0.243 | 0.994 (0.938-1.052) | 0.823 |
Maximum dose (Gy) | 0.997 (0.907-1.094) | 0.940 | 0.983 (0.939-1.029) | 0.455 |
Mean dose (Gy) | 1.060 (0.952-1.180) | 0.286 | 0.991 (0.937-1.048) | 0.750 |
EQD210 prescribed (Gy) | 1.007 (0.938-1.081) | 0.844 | 0.984 (0.944-1.025) | 0.440 |
EQD210 Maximum (Gy) | 0.975 (0.940-1.012) | 0.184 | 0.996 (0.977-1.017) | 0.723 |
EQD210 Mean (Gy) | 0.971 (0.933-1.012) | 0.148 | 0.993 (0.973-1.013) | 0.474 |